:: Class Utilisation Summary 2007
See LEGEND for key to shading and symbols.
:: Subject Area - PHPH Term - Semester 1
Data is correct as at Tue Dec 4 02:00:25 EST 2007
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
PHPH2101 | Physiology 1A | ||||||
LAB | T14A | 5017 | Rel | Full | 137/133 | > 100% | Tue 14-17 (w2-5,7-14, See School) |
LAB | W10A | 5018 | Rel | Open | 139/180 | 77% | Wed 10-13 (w2-5,7-14, See School) |
LE1 | A | 5015 | Auto | Open | 276/300 | 92% | Mon 11 (Burrows Th); Tue 13 (Burrows Th) |
LE2 | B | 5016 | Rel | Open | 276/300 | 92% | Thu 13 (w1,3,5-6,9,11,13, Burrows Th) |
TUT | H13A | 5019 | Enr | Tent | 0/45 | 0% | Thu 13 (w2,4,7,10,12,14, F21 1039) |
TUT | H13B | 5020 | Enr | Tent | 0/45 | 0% | Thu 13 (w2,4,7,10,12,14, CLB 2) |
TUT | H13C | 5021 | Enr | Open | 48/60 | 80% | Thu 13 (w2,4,7,10,12,14, Biomed ThD) |
TUT | H13D | 5022 | Enr | Open | 57/60 | 95% | Thu 13 (w2,4,7,10,12,14, Biomed ThC) |
TUT | H13E | 5023 | Enr | Tent | 0/50 | 0% | Thu 13 (w2,4,7,10,12,14, Biomed ThA) |
TUT | H13F | 5024 | Enr | Tent | 0/45 | 0% | Thu 13 (w2,4,7,10,12,14, Quad G031) |
TUT | H13G | 5025 | Enr | Open | 55/60 | 92% | Thu 13 (w2,4,7,10,12,14, Biomed ThF) |
TUT | H13H | 5026 | Enr | Tent | 0/24 | 0% | Thu 13 (w2,4,7,10,12,14, Sam 306) |
TUT | H13I | 5027 | Enr | Open | 57/60 | 95% | Thu 13 (w2,4,7,10,12,14, MathewsThC) |
TUT | H13J | 5028 | Enr | Open | 59/60 | 98% | Thu 13 (w2,4,7,10,12,14, MathewsThB) |
PHPH2121 | Principles of Physiology A | ||||||
LAB | T14A | 5031 | Rel | Full | 9/8 | > 100% | Tue 14-17 (w2-5,7-14, Wurth 204) |
LAB | T14B | 5032 | Rel | Full | 9/8 | > 100% | Tue 14-17 (w2-5,7-14, Wurth 202) |
LAB | T14C | 5033 | Rel | Tent | 0/0 | N/A | Tue 14-17 (w2-5,7-14) |
LAB | T14D | 5034 | Rel | Tent | 0/0 | N/A | Tue 14-17 (w2-5,7-14) |
LAB | W10A | 5035 | Rel | Open | 23/50 | 46% | Wed 10-13 (w2-5,7-14, Wurth 204) |
LAB | W10B | 5036 | Rel | Open | 12/50 | 24% | Wed 10-13 (w2-5,7-14, Wurth 202) |
LAB | W10C | 5037 | Rel | Tent | 0/0 | N/A | Wed 10-13 (w2-5,7-14) |
LAB | W10D | 5038 | Rel | Tent | 0/0 | N/A | Wed 10-13 (w2-5,7-14) |
LE1 | A | 5029 | Auto | Open | 53/70 | 76% | Mon 11 (Burrows Th); Tue 13 (Burrows Th) |
LE2 | B | 5030 | Rel | Open | 53/70 | 76% | Thu 13 (w1,3,5-6,9,11,13, Burrows Th) |
TUT | F12A | 5049 | Enr | Tent | 0/10 | 0% | Fri 12 (w2,4,7,10,12,14, Mat 102) |
TUT | F12B | 5050 | Enr | Tent | 0/10 | 0% | Fri 12 (w2,4,7,10,12,14, Sam 306) |
TUT | H13A | 5039 | Enr | Tent | 0/10 | 0% | Thu 13 (w2,4,7,10,12,14, F21 1039) |
TUT | H13B | 5040 | Enr | Tent | 0/10 | 0% | Thu 13 (w2,4,7,10,12,14, CLB 2) |
TUT | H13C | 5041 | Enr | Open | 44/60 | 73% | Thu 13 (w2,4,7,10,12,14, Biomed ThD) |
TUT | H13D | 5042 | Enr | Open | 9/10 | 90% | Thu 13 (w2,4,7,10,12,14, Biomed ThC) |
TUT | H13E | 5043 | Enr | Tent | 0/10 | 0% | Thu 13 (w2,4,7,10,12,14, Biomed ThA) |
TUT | H13F | 5044 | Enr | Tent | 0/10 | 0% | Thu 13 (w2,4,7,10,12,14, Quad G031) |
TUT | H13G | 5045 | Enr | Tent | 0/10 | 0% | Thu 13 (w2,4,7,10,12,14, Biomed ThF) |
TUT | H13H | 5046 | Enr | Tent | 0/10 | 0% | Thu 13 (w2,4,7,10,12,14, Sam 306) |
TUT | H13I | 5047 | Enr | Tent | 0/10 | 0% | Thu 13 (w2,4,7,10,12,14, MathewsThC) |
TUT | H13J | 5048 | Enr | Tent | 0/10 | 0% | Thu 13 (w2,4,7,10,12,14, MathewsThB) |
PHPH2501 | Human Physiology A | ||||||
LAB | T14A | 6060 | Rel | Full | 32/32 | 100% | Tue 14-17 (w2-5,7-14, Wurth 204) |
LAB | T14B | 6061 | Rel | Full | 31/30 | > 100% | Tue 14-17 (w2-5,7-14, Wurth 202) |
LAB | T14C | 6062 | Rel | Tent | 0/0 | N/A | Tue 14-17 (w2-5,7-14) |
LAB | T14D | 6063 | Rel | Tent | 0/0 | N/A | Tue 14-17 (w2-5,7-14) |
LAB | W10A | 6064 | Rel | Open | 19/50 | 38% | Wed 10-13 (w2-5,7-14, Wurth 204) |
LAB | W10B | 6065 | Rel | Open | 5/50 | 10% | Wed 10-13 (w2-5,7-14, Wurth 202) |
LAB | W10C | 6066 | Rel | Tent | 0/0 | N/A | Wed 10-13 (w2-5,7-14) |
LAB | W10D | 6067 | Rel | Tent | 0/0 | N/A | Wed 10-13 (w2-5,7-14) |
LE1 | A | 6058 | Auto | Open | 87/120 | 73% | Mon 11 (Burrows Th); Tue 13 (Burrows Th) |
LE2 | B | 6059 | Rel | Open | 87/120 | 73% | Thu 13 (w1,3,5-6,9,11,13, Burrows Th) |
TUT | H13A | 6068 | Enr | Tent | 0/9 | 0% | Thu 13 (w2,4,7,10,12,14, F21 1039) |
TUT | H13B | 6069 | Enr | Tent | 0/9 | 0% | Thu 13 (w2,4,7,10,12,14, CLB 2) |
TUT | H13C | 6070 | Enr | Tent | 0/9 | 0% | Thu 13 (w2,4,7,10,12,14, Biomed ThD) |
TUT | H13D | 6071 | Enr | Tent | 0/9 | 0% | Thu 13 (w2,4,7,10,12,14, Biomed ThC) |
TUT | H13E | 6072 | Enr | Open | 87/120 | 73% | Thu 13 (w2,4,7,10,12,14, Biomed ThA) |
TUT | H13F | 6073 | Enr | Tent | 0/9 | 0% | Thu 13 (w2,4,7,10,12,14, Quad G031) |
TUT | H13G | 6074 | Enr | Tent | 0/9 | 0% | Thu 13 (w2,4,7,10,12,14, Biomed ThF) |
TUT | H13H | 6075 | Enr | Tent | 0/9 | 0% | Thu 13 (w2,4,7,10,12,14, Sam 306) |
TUT | H13I | 6076 | Enr | Tent | 0/9 | 0% | Thu 13 (w2,4,7,10,12,14, MathewsThC) |
TUT | H13J | 6077 | Enr | Tent | 0/9 | 0% | Thu 13 (w2,4,7,10,12,14, MathewsThB) |
PHPH3121 | Membrane & Cellular Physiology | ||||||
LAB | TU12 | 7995 | Rel | Open | 48/60 | 80% | Tue 13-16 |
LEC | T09A | 5051 | Enr | Open | 48/60 | 80% | Tue 10-13 (Wurth 501) |
PHPH3211 | Cardiovascular Physiology and | ||||||
LEC | H09A | 5052 | Enr | Full | 82/82 | 100% | Thu 14-16 (w1,10,12, Wurth 501); Thu 14-17 (w2,3, Wurth 501) |
PHPH3251 | Clinical & Exp'l Pharmacology | ||||||
LAB | F14A | 5054 | Enr | Open | 37/40 | 93% | Wed 14-17 (w3,6,12,14) |
LAB | F14B | 5055 | Enr | Open | 39/40 | 98% | Wed 14-17 (w2,5,11,13) |
LEC | A | 5053 | Auto | Open | 76/80 | 95% | Mon Wed 13-14 (w1-6, Biomed ThC); Mon Wed 13-14 (w7-14, Biomed ThC) |
TU1 | F14C | 5056 | Rel | Open | 76/80 | 95% | Wed 14-17 (w4,7-8,10, Wurth 501) |
TU2 | F14D | 5057 | Rel | Open | 37/40 | 93% | Wed 14-17 (w2,5,11,13, Wurth 501) |
TU2 | F14E | 5058 | Rel | Open | 39/40 | 98% | Wed 14-17 (w3,6,12,14, Wurth 501) |
PHPH3502 | Skeletal Muscle in Hlth&Exer. | ||||||
LEC | A | 6078 | Enr | Open | 17/30 | 57% | Wed 10-17 (w7-14); Wed 10-17 (w1-6, Wurth 501) |
PHPH4218 | Physiology Honours Full-Time | ||||||
HON | 001 | 9382 | Enr | Open* | 5/30 | 17% | |
PHPH4224 | Physiology Honours Part-Time | ||||||
HON | 001 | 9383 | Enr | Open* | 0/30 | 0% | |
PHPH4258 | Pharmacology Honours Full-Time | ||||||
HON | 001 | 9384 | Enr | Open* | 7/30 | 23% | |
PHPH4264 | Pharmacology Honours Part-Time | ||||||
HON | 001 | 9385 | Enr | Open* | 1/30 | 3% | |
PHPH5394 | (P/T) Research Thesis Physiol | ||||||
THE | 0001 | 8619 | Enr | Open* | 8/30 | 27% | |
PHPH5398 | (F/T) Research Thesis Physiol | ||||||
THE | 0001 | 8586 | Enr | Open | 23/2000 | 1% | |
PHPH5401 | Sports Injuries 1 | ||||||
DST | 0001 | 9389 | Enr | Open | 5/30 | 17% | |
PHPH5411 | Sports Injuries 2 | ||||||
DST | 0001 | 9390 | Enr | Open | 8/50 | 16% | |
PHPH5420 | Sports Psychology | ||||||
DST | 0001 | 9396 | Enr | Open | 5/30 | 17% | |
PHPH5421 | Sports Injuries 3 | ||||||
DST | 0001 | 9391 | Enr | Open | 17/30 | 57% | |
PHPH5440 | Clinical Skills Training 1 | ||||||
DST | 0001 | 9401 | Enr | Closed* | 0/30 | 0% | |
PHPH5445 | Research Project and Report | ||||||
DST | 0001 | 9399 | Enr | Open | 3/30 | 10% | |
PHPH5450 | Clinical Skills Training 2 | ||||||
DST | 0001 | 9402 | Enr | Open | 20/30 | 67% | |
PHPH5453 | Major Project and Report | ||||||
DST | 0001 | 9400 | Enr | Open* | 0/30 | 0% | |
PHPH5470 | Sports Nutrition | ||||||
DST | 0001 | 9394 | Enr | Open | 15/30 | 50% | |
PHPH5510 | Sports Pharmacology | ||||||
DST | 0001 | 9395 | Enr | Open | 7/30 | 23% | |
PHPH5530 | Clinical Biomechanics | ||||||
DST | 0001 | 9397 | Enr | Open | 10/30 | 33% | |
PHPH5571 | Research Methods | ||||||
DST | 0001 | 9398 | Enr | Open | 7/30 | 23% | |
PHPH5591 | Paediatric Sports Medicine | ||||||
DST | 0001 | 9392 | Enr | Open | 5/30 | 17% | |
PHPH5611 | Applied Sports Medicine | ||||||
DST | 0001 | 9393 | Enr | Open* | 1/30 | 3% | |
PHPH9100 | Discovery & Development of Med | ||||||
LEC | 0001 | 1583 | Enr | Open* | 0/100 | 0% | |
PHPH9101 | Principles of Drug Action | ||||||
LEC | 0001 | 1582 | Enr | Open* | 51/100 | 51% | |
PHPH9102 | Pharm. Develp of New Medicines | ||||||
LEC | 0001 | 1584 | Enr | Open* | 25/100 | 25% | |
PHPH9107 | Therapeutics & Molec Basis of | ||||||
LEC | 0001 | 1586 | Enr | Open* | 11/100 | 11% | |
PHPH9111 | Pharmaceutical Formulation 2 | ||||||
LEC | 0001 | 1588 | Enr | Open* | 8/100 | 8% | |
PHPH9114 | Pharmacoeconomics | ||||||
LEC | 0001 | 1589 | Enr | Open* | 11/100 | 11% | |
PHPH9118 | Therap&Molec Basis of Disease2 | ||||||
LEC | 0001 | 1587 | Enr | Open* | 10/100 | 10% | |
PHPH9121 | Postmarketing Development Med | ||||||
LEC | 0001 | 1585 | Enr | Open* | 20/100 | 20% | |
PHPH9127 | Safety and Efficacy | ||||||
OTH | 0001 | 8884 | Enr | Full* | 54/50 | > 100% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by Deputy Vice Chancellor (Academic) & Registrar Privacy Statement Copyright & Disclaimer |